The synthesis of retatrutide, a novel dual stimulant targeting both GLP-1 and GIP receptors, represents a complex complicated chemical process. Preliminary routes focused on protein section coupling, utilizing solid-phase production methodologies to build the long protein sequence. Subsequent investigation has explored various approaches, including